NO20000123L - Ny formulering - Google Patents

Ny formulering

Info

Publication number
NO20000123L
NO20000123L NO20000123A NO20000123A NO20000123L NO 20000123 L NO20000123 L NO 20000123L NO 20000123 A NO20000123 A NO 20000123A NO 20000123 A NO20000123 A NO 20000123A NO 20000123 L NO20000123 L NO 20000123L
Authority
NO
Norway
Prior art keywords
wording
new
new wording
Prior art date
Application number
NO20000123A
Other languages
English (en)
Other versions
NO20000123D0 (no
NO329918B1 (no
Inventor
Joanne Broadhead
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000123(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO20000123D0 publication Critical patent/NO20000123D0/no
Publication of NO20000123L publication Critical patent/NO20000123L/no
Publication of NO329918B1 publication Critical patent/NO329918B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20000123A 1997-07-11 2000-01-10 Farmasoytisk preparat, samt fremgangsmate til fremstilling derav NO329918B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702680A SE9702680D0 (sv) 1997-07-11 1997-07-11 New formulation
PCT/SE1998/001287 WO1999002542A1 (en) 1997-07-11 1998-06-29 New formulation

Publications (3)

Publication Number Publication Date
NO20000123D0 NO20000123D0 (no) 2000-01-10
NO20000123L true NO20000123L (no) 2000-03-03
NO329918B1 NO329918B1 (no) 2011-01-24

Family

ID=20407718

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000123A NO329918B1 (no) 1997-07-11 2000-01-10 Farmasoytisk preparat, samt fremgangsmate til fremstilling derav

Country Status (35)

Country Link
US (1) US6130208A (no)
EP (1) EP1000079B1 (no)
JP (1) JP4950380B2 (no)
KR (1) KR100786654B1 (no)
CN (2) CN1864696A (no)
AR (1) AR013157A1 (no)
AT (1) ATE340801T1 (no)
AU (1) AU8362598A (no)
BR (1) BR9810703A (no)
CA (1) CA2295628C (no)
CY (1) CY1105805T1 (no)
CZ (1) CZ298110B6 (no)
DE (1) DE69836023T2 (no)
DK (1) DK1000079T3 (no)
EE (1) EE04119B1 (no)
ES (1) ES2273425T3 (no)
HU (1) HU226489B1 (no)
ID (1) ID24716A (no)
IL (2) IL133868A0 (no)
IS (1) IS2439B (no)
MY (1) MY116421A (no)
NO (1) NO329918B1 (no)
NZ (1) NZ502073A (no)
PL (1) PL192768B1 (no)
PT (1) PT1000079E (no)
RU (1) RU2216330C2 (no)
SA (1) SA98190328B1 (no)
SE (1) SE9702680D0 (no)
SI (1) SI1000079T1 (no)
SK (1) SK285766B6 (no)
TR (1) TR200000006T2 (no)
TW (1) TW585764B (no)
UA (1) UA65576C2 (no)
WO (1) WO1999002542A1 (no)
ZA (1) ZA985669B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879567B2 (en) * 2004-10-05 2011-02-01 Asahi Kasei Pharma Corporation Method for stabilizing coenzyme and composition therefor
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
ES2470329T3 (es) 2009-08-28 2014-06-23 Daiichi Sankyo Company, Limited Derivado del ácido 3-(biariloxi) priopi�nico
PT2498731T (pt) 2009-11-11 2020-02-21 Chiesi Farm Spa Métodos de tratamento ou prevenção de uma trombose de endoprótese
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
RU2606845C2 (ru) * 2010-12-10 2017-01-10 СИГМАФАРМ ЛЭБОРЭТОРИЗ, ЭлЭлСи Высокостабильные композиции перорально активных аналогов нуклеотидов или перорально активных пролекарств аналогов нуклеотидов
AU2012214396B2 (en) 2011-02-09 2017-04-27 Chiesi Farmaceutici S.P.A. Methods for treating pulmonary hypertension
DK2744424T3 (en) 2011-08-17 2018-01-22 Samuel Shiber Adaptively rotating catheter to open clogged vessels in the body
BR112015022070B1 (pt) 2013-03-09 2022-01-18 Chiesi Farmaceutici S.P.A. Uso de cangrelor
CN103772461A (zh) * 2014-01-06 2014-05-07 南京正科制药有限公司 一种坎格雷洛晶型ⅰ
EP3244900A4 (en) 2015-01-14 2018-05-30 Chiesi Farmaceutici S.p.A. Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
US11260071B2 (en) 2017-06-23 2022-03-01 Chiesi Farmaceutici S.P.A. Method of preventing of systemic-to-pulmonary-artery shunt thrombosis
TWI857957B (zh) 2018-06-19 2024-10-11 德商Ｕｃｂ製藥有限公司 吡啶基及吡基-（氮）吲哚磺醯胺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (no) * 1973-05-17 1981-09-03
JPS5874966A (ja) * 1981-10-28 1983-05-06 Mikuni Jukogyo Kk 高圧往復動機の軸封装置
JPS5874696A (ja) * 1981-10-30 1983-05-06 株式会社　ヤトロン アデノシン三リン酸の安定化方法
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
AU3095092A (en) * 1991-12-09 1993-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
SK281309B6 (sk) * 1993-02-10 2001-02-12 Astra Pharmaceuticals Limited N-alkyl-2-substituované adenozíntrifosfátové deriváty, spôsob ich prípravy, farmaceutické prostriedky obsahujúce tieto deriváty a použitie týchto derivátov
ZA949715B (en) * 1993-12-14 1996-06-06 Lilly Co Eli Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins and pharmaceutical formulations and methods thereof
DE4405426A1 (de) * 1994-02-21 1995-08-24 Boehringer Mannheim Gmbh Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
CA2223921A1 (en) * 1995-06-07 1996-12-19 Francis C. Szoka, Jr. Stabilization of polynucleotide complexes
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
ID21635A (id) * 1996-12-20 1999-07-08 Astra Pharma Prod Komposisi farmasi untuk pengeringan beku

Also Published As

Publication number Publication date
AR013157A1 (es) 2000-12-13
SI1000079T1 (sl) 2007-08-31
CN1864696A (zh) 2006-11-22
PL192768B1 (pl) 2006-12-29
WO1999002542A1 (en) 1999-01-21
CY1105805T1 (el) 2011-02-02
IL133868A (en) 2010-05-17
MY116421A (en) 2004-01-31
EP1000079B1 (en) 2006-09-27
US6130208A (en) 2000-10-10
DE69836023D1 (de) 2006-11-09
BR9810703A (pt) 2000-08-08
DK1000079T3 (da) 2006-11-20
IS2439B (is) 2008-11-15
CA2295628A1 (en) 1999-01-21
SE9702680D0 (sv) 1997-07-11
NZ502073A (en) 2001-09-28
KR20010021647A (ko) 2001-03-15
PL337970A1 (en) 2000-09-11
ID24716A (id) 2000-08-03
ZA985669B (en) 1999-01-11
EE04119B1 (et) 2003-08-15
SA98190328B1 (ar) 2006-08-15
UA65576C2 (uk) 2004-04-15
SK183699A3 (en) 2000-07-11
HK1026429A1 (en) 2000-12-15
SK285766B6 (sk) 2007-07-06
ATE340801T1 (de) 2006-10-15
NO20000123D0 (no) 2000-01-10
IS5331A (is) 1999-12-30
TW585764B (en) 2004-05-01
JP4950380B2 (ja) 2012-06-13
PT1000079E (pt) 2006-12-29
CZ200083A3 (cs) 2000-06-14
EP1000079A1 (en) 2000-05-17
DE69836023T2 (de) 2007-04-12
ES2273425T3 (es) 2007-05-01
HUP0002622A3 (en) 2002-04-29
RU2216330C2 (ru) 2003-11-20
AU8362598A (en) 1999-02-08
HU226489B1 (en) 2009-03-02
EE200000022A (et) 2000-10-16
CA2295628C (en) 2008-07-29
KR100786654B1 (ko) 2007-12-21
JP2001509512A (ja) 2001-07-24
NO329918B1 (no) 2011-01-24
TR200000006T2 (tr) 2000-07-21
HUP0002622A2 (hu) 2001-05-28
IL133868A0 (en) 2001-04-30
CZ298110B6 (cs) 2007-06-27
CN1263533A (zh) 2000-08-16

Similar Documents

Publication Publication Date Title
NO20001830D0 (no) Ny kombinasjon
DE69835685D1 (de) Mehrtransaktionsmünzgerät
DE69839729D1 (de) Signallisierungsnetzdurchgangssystem
DE69818302D1 (de) Perfusionsverbindungsvorrichtung
DE69840589D1 (de) erungsvorrichtung
DE69834142D1 (de) Tintenzuführsystemadapter
DE69838649D1 (de) Faltgestellgerät
DE69827636D1 (de) Blutverdünnungsreagenz
DE69806057D1 (de) Schubdüsenverstelleinrichtung
DE69836021D1 (de) Filteranordung
DE69812610D1 (de) Gurtschlossspanner
DE69804327D1 (de) Notfluchtatemgerät
NO994431D0 (no) Ny formulering
DE69819648D1 (de) Zweitorpuffer
DE69806297D1 (de) Bilddekodiergerät
DE69817473D1 (de) Halbtonrasterungssystem
NO20000123L (no) Ny formulering
PT1036083E (pt) Novos 9a-azalidos
DE69733411D1 (de) Störisolierungsschaltung
DE69818382D1 (de) Injektor
NO20002555D0 (no) Skjøt
DE69831786D1 (de) Kommutationsregler
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
DE69820582D1 (de) Informationsverarbeitingssystem
ID25585A (id) Senyawa-senyawa

Legal Events

Date Code Title Description
MK1K Patent expired